The convergence of artificial intelligence (AI) and organoid technology is significantly advancing precision and predictive medicine. This integration offers physiologically relevant 3D models and lev
Anthropic has launched Claude Science, an AI workbench specifically designed for pharmaceutical researchers, aiming to automate and accelerate drug discovery processes. The new product is intended to
AI giant Anthropic has introduced Claude Science, an AI workbench tailored for biopharmaceutical research, and announced its direct entry into drug discovery programs, initially targeting neglected di
Takeda has entered a strategic collaboration with Insilico Medicine to utilize its AI-based Pharma.AI platform for the discovery and development of novel drug candidates across Takeda's therapeutic ar
Researchers have successfully used ultrasound and artificial intelligence to guide algae microrobots in delivering chemotherapy deep into tumors in mice. This innovative approach shows promise for imp
Takeda has announced a strategic collaboration with Insilico Medicine, a leader in generative AI for drug discovery, to advance drug candidates across its therapeutic areas. The deal includes a $60 mi